SEC Comment Letter for Apollomics (APLM) — Mar 11, 2026
Apollomics Inc.
Date: March 11, 2026 · CIK: 0001944885 · Accession: 0000000000-26-002490
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-294154
Letter
Re: Apollomics Inc. Registration Statement on F-3 Filed March 9, 2026 File No. 333-294154 Dear Howard Chen:
March 11, 2026
Howard Chen Chief Executive Officer Apollomics Inc. 989 E. Hillsdale Blvd., Suite 220 Foster City, CA 94404
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Chris Edwards at 202-551-6761 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Alison Pear Buchalter
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> March 11, 2026 Howard Chen Chief Executive Officer Apollomics Inc. 989 E. Hillsdale Blvd., Suite 220 Foster City, CA 94404 Re: Apollomics Inc. Registration Statement on F-3 Filed March 9, 2026 File No. 333-294154 Dear Howard Chen: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Chris Edwards at 202-551-6761 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Alison Pear Buchalter </TEXT> </DOCUMENT>